 | • レポートコード：GIR201102889 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、避妊薬の世界市場を調査対象にし、避妊薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（長期避妊、短期避妊、緊急避妊）、用途別分析（病院薬局、小売薬局、オンライン薬局、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Bayer AG、Novo Nordisk A/S、Merck & Co., Inc、Pfizer, Inc、Gedeon Richter、Teva Pharmaceutical Industries Ltd、Baijingyu、Johnson & Johnson、Actavis, Inc.、ZiZhu、Huazhong、Sine ・メーカー別販売量、売上、市場シェア ・避妊薬の地域別市場分析 ・避妊薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・避妊薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・避妊薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・避妊薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・避妊薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・避妊薬の種類別市場規模2015-2020：長期避妊、短期避妊、緊急避妊 ・避妊薬の用途別市場規模2015-2020：病院薬局、小売薬局、オンライン薬局、その他 ・避妊薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4%% in the forecast period of 2020 to 2025 and will expected to reach USD 2056.1 million by 2025, from USD 1872.7 million in 2019.
Market segmentation
Contraceptives market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Contraceptives market has been segmented into
Prolonged Contraception
Short-term Contraception
Emergency Contraception
By Application, Contraceptives has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Contraceptives market presented in the report. This section sheds light on the sales growth of different regional and country-level Contraceptives markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contraceptives market.
The report offers in-depth assessment of the growth and other aspects of the Contraceptives market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Contraceptives Market Share Analysis
Contraceptives competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contraceptives sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contraceptives sales, revenue and market share for each player covered in this report.
The major players covered in Contraceptives are:
Bayer AG
Novo Nordisk A/S
Merck & Co., Inc
Pfizer, Inc
Gedeon Richter
Teva Pharmaceutical Industries Ltd
Baijingyu
Johnson & Johnson
Actavis, Inc.
ZiZhu
Huazhong
Sine
Among other players domestic and global, Contraceptives market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Contraceptives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Contraceptives, with price, sales, revenue and global market share of Contraceptives in 2018 and 2019.
Chapter 3, the Contraceptives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Contraceptives sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptives Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prolonged Contraception
1.2.3 Short-term Contraception
1.2.4 Emergency Contraception
1.3 Market Analysis by Application
1.3.1 Overview: Global Contraceptives Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Overview of Global Contraceptives Market
1.4.1 Global Contraceptives Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG SWOT Analysis
2.1.4 Bayer AG Product and Services
2.1.5 Bayer AG Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S SWOT Analysis
2.2.4 Novo Nordisk A/S Product and Services
2.2.5 Novo Nordisk A/S Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck & Co., Inc
2.3.1 Merck & Co., Inc Details
2.3.2 Merck & Co., Inc Major Business
2.3.3 Merck & Co., Inc SWOT Analysis
2.3.4 Merck & Co., Inc Product and Services
2.3.5 Merck & Co., Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business
2.4.3 Pfizer, Inc SWOT Analysis
2.4.4 Pfizer, Inc Product and Services
2.4.5 Pfizer, Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gedeon Richter
2.5.1 Gedeon Richter Details
2.5.2 Gedeon Richter Major Business
2.5.3 Gedeon Richter SWOT Analysis
2.5.4 Gedeon Richter Product and Services
2.5.5 Gedeon Richter Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries Ltd
2.6.1 Teva Pharmaceutical Industries Ltd Details
2.6.2 Teva Pharmaceutical Industries Ltd Major Business
2.6.3 Teva Pharmaceutical Industries Ltd Product and Services
2.6.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baijingyu
2.7.1 Baijingyu Details
2.7.2 Baijingyu Major Business
2.7.3 Baijingyu Product and Services
2.7.4 Baijingyu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Product and Services
2.8.4 Johnson & Johnson Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Actavis, Inc.
2.9.1 Actavis, Inc. Details
2.9.2 Actavis, Inc. Major Business
2.9.3 Actavis, Inc. Product and Services
2.9.4 Actavis, Inc. Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 ZiZhu
2.10.1 ZiZhu Details
2.10.2 ZiZhu Major Business
2.10.3 ZiZhu Product and Services
2.10.4 ZiZhu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Product and Services
2.11.4 Huazhong Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sine
2.12.1 Sine Details
2.12.2 Sine Major Business
2.12.3 Sine Product and Services
2.12.4 Sine Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Contraceptives Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Contraceptives Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Contraceptives Manufacturer Market Share in 2019
3.3.2 Top 6 Contraceptives Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Contraceptives Sales, Revenue and Market Share by Regions
4.1.1 Global Contraceptives Sales and Market Share by Regions (2015-2020)
4.1.2 Global Contraceptives Revenue and Market Share by Regions (2015-2020)
4.2 North America Contraceptives Sales and Growth Rate (2015-2020)
4.3 Europe Contraceptives Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Contraceptives Sales and Growth Rate (2015-2020)
4.5 South America Contraceptives Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Contraceptives Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Contraceptives Sales, Revenue and Market Share by Country
5.1.1 North America Contraceptives Sales and Market Share by Country (2015-2020)
5.1.2 North America Contraceptives Revenue and Market Share by Country (2015-2020)
5.2 United States Contraceptives Sales and Growth Rate (2015-2020)
5.3 Canada Contraceptives Sales and Growth Rate (2015-2020)
5.4 Mexico Contraceptives Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Contraceptives Sales, Revenue and Market Share by Country
6.1.1 Europe Contraceptives Sales and Market Share by Country (2015-2020)
6.1.2 Europe Contraceptives Revenue and Market Share by Country (2015-2020)
6.2 Germany Contraceptives Sales and Growth Rate (2015-2020)
6.3 UK Contraceptives Sales and Growth Rate (2015-2020)
6.4 France Contraceptives Sales and Growth Rate (2015-2020)
6.5 Russia Contraceptives Sales and Growth Rate (2015-2020)
6.6 Italy Contraceptives Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Contraceptives Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Contraceptives Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Contraceptives Revenue and Market Share by Regions (2015-2020)
7.2 China Contraceptives Sales and Growth Rate (2015-2020)
7.3 Japan Contraceptives Sales and Growth Rate (2015-2020)
7.4 Korea Contraceptives Sales and Growth Rate (2015-2020)
7.5 India Contraceptives Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Contraceptives Sales and Growth Rate (2015-2020)
7.7 Australia Contraceptives Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Contraceptives Sales, Revenue and Market Share by Country
8.1.1 South America Contraceptives Sales and Market Share by Country (2015-2020)
8.1.2 South America Contraceptives Revenue and Market Share by Country (2015-2020)
8.2 Brazil Contraceptives Sales and Growth Rate (2015-2020)
8.3 Argentina Contraceptives Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Contraceptives Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Contraceptives Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Contraceptives Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Contraceptives Sales and Growth Rate (2015-2020)
9.3 Turkey Contraceptives Sales and Growth Rate (2015-2020)
9.4 Egypt Contraceptives Sales and Growth Rate (2015-2020)
9.5 South Africa Contraceptives Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Contraceptives Sales and Market Share by Type (2015-2020)
10.2 Global Contraceptives Revenue and Market Share by Type (2015-2020)
10.3 Global Contraceptives Price by Type (2015-2020)
11 Global Contraceptives Market Segment by Application
11.1 Global Contraceptives Sales Market Share by Application (2015-2020)
11.2 Global Contraceptives Revenue Market Share by Application (2015-2020)
11.3 Global Contraceptives Price by Application (2015-2020)
12 Market Forecast
12.1 Global Contraceptives Sales, Revenue and Growth Rate (2021-2025)
12.2 Contraceptives Market Forecast by Regions (2021-2025)
12.2.1 North America Contraceptives Market Forecast (2021-2025)
12.2.2 Europe Contraceptives Market Forecast (2021-2025)
12.2.3 Asia-Pacific Contraceptives Market Forecast (2021-2025)
12.2.4 South America Contraceptives Market Forecast (2021-2025)
12.2.5 Middle East & Africa Contraceptives Market Forecast (2021-2025)
12.3 Contraceptives Market Forecast by Type (2021-2025)
12.3.1 Global Contraceptives Sales Forecast by Type (2021-2025)
12.3.2 Global Contraceptives Market Share Forecast by Type (2021-2025)
12.4 Contraceptives Market Forecast by Application (2021-2025)
12.4.1 Global Contraceptives Sales Forecast by Application (2021-2025)
12.4.2 Global Contraceptives Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Contraceptives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Contraceptives Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Contraceptives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 9. Bayer AG Contraceptives Major Business
Table 10. Bayer AG Contraceptives Total Revenue (USD Million) (2018-2019)
Table 11. Bayer AG SWOT Analysis
Table 12. Bayer AG Contraceptives Product and Services
Table 13. Bayer AG Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 15. Novo Nordisk A/S Contraceptives Major Business
Table 16. Novo Nordisk A/S Contraceptives Total Revenue (USD Million) (2018-2019)
Table 17. Novo Nordisk A/S SWOT Analysis
Table 18. Novo Nordisk A/S Contraceptives Product and Services
Table 19. Novo Nordisk A/S Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 21. Merck & Co., Inc Contraceptives Major Business
Table 22. Merck & Co., Inc Contraceptives Total Revenue (USD Million) (2018-2019)
Table 23. Merck & Co., Inc SWOT Analysis
Table 24. Merck & Co., Inc Contraceptives Product and Services
Table 25. Merck & Co., Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer, Inc Contraceptives Major Business
Table 28. Pfizer, Inc Contraceptives Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer, Inc SWOT Analysis
Table 30. Pfizer, Inc Contraceptives Product and Services
Table 31. Pfizer, Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 33. Gedeon Richter Contraceptives Major Business
Table 34. Gedeon Richter Contraceptives Total Revenue (USD Million) (2018-2019)
Table 35. Gedeon Richter SWOT Analysis
Table 36. Gedeon Richter Contraceptives Product and Services
Table 37. Gedeon Richter Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Teva Pharmaceutical Industries Ltd Contraceptives Major Business
Table 40. Teva Pharmaceutical Industries Ltd Contraceptives Total Revenue (USD Million) (2018-2019)
Table 41. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 42. Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
Table 43. Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 45. Baijingyu Contraceptives Major Business
Table 46. Baijingyu Contraceptives Total Revenue (USD Million) (2018-2019)
Table 47. Baijingyu SWOT Analysis
Table 48. Baijingyu Contraceptives Product and Services
Table 49. Baijingyu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 51. Johnson & Johnson Contraceptives Major Business
Table 52. Johnson & Johnson Contraceptives Total Revenue (USD Million) (2018-2019)
Table 53. Johnson & Johnson SWOT Analysis
Table 54. Johnson & Johnson Contraceptives Product and Services
Table 55. Johnson & Johnson Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 57. Actavis, Inc. Contraceptives Major Business
Table 58. Actavis, Inc. Contraceptives Total Revenue (USD Million) (2018-2019)
Table 59. Actavis, Inc. SWOT Analysis
Table 60. Actavis, Inc. Contraceptives Product and Services
Table 61. Actavis, Inc. Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 63. ZiZhu Contraceptives Major Business
Table 64. ZiZhu Contraceptives Total Revenue (USD Million) (2018-2019)
Table 65. ZiZhu SWOT Analysis
Table 66. ZiZhu Contraceptives Product and Services
Table 67. ZiZhu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Huazhong Basic Information, Manufacturing Base and Competitors
Table 69. Huazhong Contraceptives Major Business
Table 70. Huazhong Contraceptives Total Revenue (USD Million) (2018-2019)
Table 71. Huazhong SWOT Analysis
Table 72. Huazhong Contraceptives Product and Services
Table 73. Huazhong Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Sine Basic Information, Manufacturing Base and Competitors
Table 75. Sine Contraceptives Major Business
Table 76. Sine Contraceptives Total Revenue (USD Million) (2018-2019)
Table 77. Sine SWOT Analysis
Table 78. Sine Contraceptives Product and Services
Table 79. Sine Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Contraceptives Sales by Manufacturer (2018-2019) (MT)
Table 81. Global Contraceptives Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Contraceptives Sales by Regions (2015-2020) (MT)
Table 83. Global Contraceptives Sales Market Share by Regions (2015-2020)
Table 84. Global Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Contraceptives Sales by Countries (2015-2020) (MT)
Table 86. North America Contraceptives Sales Market Share by Countries (2015-2020)
Table 87. North America Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Contraceptives Revenue Market Share by Countries (2015-2020)
Table 89. Europe Contraceptives Sales by Countries (2015-2020) (MT)
Table 90. Europe Contraceptives Sales Market Share by Countries (2015-2020)
Table 91. Europe Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Contraceptives Sales by Regions (2015-2020) (MT)
Table 93. Asia-Pacific Contraceptives Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Contraceptives Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Contraceptives Sales by Countries (2015-2020) (MT)
Table 96. South America Contraceptives Sales Market Share by Countries (2015-2020)
Table 97. South America Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Contraceptives Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Contraceptives Sales by Countries (2015-2020) (MT)
Table 100. Middle East & Africa Contraceptives Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Contraceptives Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Contraceptives Revenue Market Share by Countries (2015-2020)
Table 103. Global Contraceptives Sales by Type (2015-2020) (MT)
Table 104. Global Contraceptives Sales Share by Type (2015-2020)
Table 105. Global Contraceptives Revenue by Type (2015-2020) (USD Million)
Table 106. Global Contraceptives Revenue Share by Type (2015-2020)
Table 107. Global Contraceptives Sales by Application (2015-2020) (MT)
Table 108. Global Contraceptives Sales Share by Application (2015-2020)
Table 109. Global Contraceptives Sales Forecast by Regions (2021-2025) (MT)
Table 110. Global Contraceptives Market Share Forecast by Regions (2021-2025)
Table 111. Global Contraceptives Sales Forecast by Type (2021-2025) (MT)
Table 112. Global Contraceptives Market Share Forecast by Type (2021-2025)
Table 113. Global Contraceptives Sales Forecast by Application (2021-2025)
Table 114. Global Contraceptives Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Contraceptives Picture
Figure 2. Global Sales Market Share of Contraceptives by Type in 2019
Figure 3. Prolonged Contraception Picture
Figure 4. Short-term Contraception Picture
Figure 5. Emergency Contraception Picture
Figure 6. Contraceptives Sales Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Others Picture
Figure 11. Global Contraceptives Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Contraceptives Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Contraceptives Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Contraceptives Sales Market Share by Manufacturer in 2019
Figure 32. Global Contraceptives Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Contraceptives Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Contraceptives Revenue Market Share by Regions (2015-2020)
Figure 39. Global Contraceptives Revenue Market Share by Regions in 2018
Figure 40. North America Contraceptives Sales and Growth Rate (2015-2020)
Figure 41. Europe Contraceptives Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Contraceptives Sales and Growth Rate (2015-2020)
Figure 43. South America Contraceptives Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Contraceptives Sales and Growth Rate (2015-2020)
Figure 45. North America Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Contraceptives Sales Market Share by Countries (2015-2020)
Figure 47. North America Contraceptives Sales Market Share by Countries in 2018
Figure 48. North America Contraceptives Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Contraceptives Revenue Market Share by Countries in 2018
Figure 50. United States Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Contraceptives Revenue Market Share by Countries in 2019
Figure 56. Germany Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Contraceptives Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Contraceptives Revenue Market Share by Regions 2019
Figure 64. China Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Contraceptives Sales Market Share by Countries in 2019
Figure 71. South America Contraceptives Revenue Market Share by Countries in 2019
Figure 72. Brazil Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Contraceptives Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Contraceptives Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Contraceptives Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Contraceptives Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Contraceptives Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Contraceptives Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Contraceptives Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Contraceptives Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
女性用避妊薬の世界市場 2020年 Market Overview The global Female Contraception Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Female Contraceptio…- 調剤医薬品の世界市場 2020年 Market Overview The global Compounding Pharmacies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.6% in the forecast period of 2020 to 2025 and will expected to reach USD 12740 million by 2025, from USD 11510 million in 2019. The Compounding Pha…
- トラコーマ治療の世界市場 2020年 Market Overview The global Trachoma Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Trachoma Treatments marke…
- めまい治療の世界市場 2020年 Market Overview The global Vertigo Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vertigo Treatments market …
- 全身性硬化症治療の世界市場 2020年 Market Overview The global Systemic Sclerosis Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Systemic Sclero…